Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

MicroVision Has Decades of Failed Hype and Not Much Else

By Ian Bezek, InvestorPlace Contributor

MicroVision might seem like a promising company. However, MVIS stock has a poor history with little reason for future optimism.

The Tilray Roller Coaster Is Set To Climb Once Again

By Ian Bezek, InvestorPlace Contributor

TLRY stock is not one for the faint of heart. However, the signs are lining up for another solid rally in Tilray to close out 2021.

The ProShares S&P Kensho Smart Factories ETF Invests In The Future of Manufacturing

By Ian Bezek, InvestorPlace Contributor

The pandemic has caused massive supply shortages. MAKX is a new ETF for investing in smart factories, a key tool in avoiding future shocks.

IonQ Is the First Publicly-Traded Quantum Computing Firm

By Ian Bezek, InvestorPlace Contributor

IonQ and quantum computing could change the world. IONQ stock represents an extremely early-stage bet on that emerging industry.

7 Quantum Computing Stocks to Buy as Rigetti Computing Comes Public

By Ian Bezek, InvestorPlace Contributor

Quantum computing is having a breakthrough moment with two high-profile firms going public. Here's how to cash in on the trend.

WallBox: Getting to Know This Global Charging Leader

By Ian Bezek, InvestorPlace Contributor

WallBox hasn't gotten much hype yet. However, this EV charging play is already generating significant revenues and WBX stock could charge on up.

QuantumScape is Still a Long Way From Showtime

By Ian Bezek, InvestorPlace Contributor

QS stock rallied on news the battery maker signed a new partnership, but there are issues with the company investors should not overlook.

Ocugen Is a Strong Sell, Vaccine Unlikely to Find Commercial Success

By Ian Bezek, InvestorPlace Contributor

Ocugen has historically had a terrible track record. There's little reason to think its current vaccine effort will end any better for OCGN stock.

Meta Materials Needs More Substance to Back Up Its Price

By Ian Bezek, InvestorPlace Contributor

Meta Materials is a fast-moving situation with a lot of moving parts. Unfortunately, it's hard to get bullish on MMAT stock at these levels.

Aterian: High Short Squeeze Potential in This Struggling Business

By Ian Bezek, InvestorPlace Contributor

Aterian has had a dreadful run of earnings and fundamental developments in 2021. However, this string of negatives could cause a squeeze in ATER stock.

Load More